Literature DB >> 8434490

Causes of false results in transthoracic fine needle lung aspirates.

P T Cagle1, M Kovach, I Ramzy.   

Abstract

To evaluate the causes of false-negative and false-positive results in transthoracic fine needle aspirates (TFNAs), we reviewed our experience with this technique over the 20-year period from 1972 to 1991. For 488 TFNAs satisfactory for cytologic interpretation, tissue diagnoses were subsequently obtained by biopsy, resection or autopsy in 218 cases (56 benign and 162 malignant). In 11 cases, TFNA was positive for malignancy, and the biopsy was negative. Review of these cases disclosed that the TFNAs were true positives (specificity, 100%) and that the biopsies failed to sample the lesion. There were 18 false-negative results by TFNA, for a sensitivity of 90%, all as a result of failure to sample the lesion. TFNA is a highly specific and sensitive technique for diagnosis of benign and malignant lung masses. False negatives are the result of failure to sample the lesion. False positives are uncommon but can be avoided if the cytopathologist is aware that benign reactive lesions may mimic malignancy on cytology.

Entities:  

Mesh:

Year:  1993        PMID: 8434490

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  Immediate assessment of fine needle aspiration cytology of lung.

Authors:  C J Stewart; I S Stewart
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

2.  Granulomatous inflammation and organizing pneumonia: Role of computed tomography-guided lung fine needle aspirations, touch preparations and core biopsies in the evaluation of common non-neoplastic diagnoses.

Authors:  Anjali Saqi; Shana M Coley; John P Crapanzano
Journal:  Cytojournal       Date:  2014-01-31       Impact factor: 2.091

3.  Cytologic-radiologic correlation using transthoracic CT-guided FNA for lung and mediastinal masses: our experience.

Authors:  Sanjay Piplani; Rahul Mannan; Monika Lalit; Mridu Manjari; Tejinder S Bhasin; Jasmin Bawa
Journal:  Anal Cell Pathol (Amst)       Date:  2014-11-25       Impact factor: 2.916

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.